IL23A and skin disorder: Our results indicate that topical Cal/BDP shows a synergistic effect on psoriasis-like dermatitis in vivo, while suppressing the expression of cytokines related to the IL-23/T17 pathogenic axis and inhibiting expansion of proinflammatory T17 cells in the dLNs.